New Zealand markets closed

Mosaic ImmunoEngineering, Inc. (CPMV)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.3900-0.0100 (-2.50%)
At close: 02:58PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.4000
Open0.3900
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.3900 - 0.3900
52-week range0.1020 - 1.0000
Volume451
Avg. volume567
Market cap2.824M
Beta (5Y monthly)-1.80
PE ratio (TTM)N/A
EPS (TTM)-0.1400
Earnings date03 Aug 2024 - 07 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend date02 Mar 2007
1y target estN/A
  • GlobeNewswire

    Oncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.

    AGOURA HILLS, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), announced today that it has entered into a binding term-sheet with Mosaic ImmunoEngineering, Inc. (OTCPK: CPMV) (“Mosaic”) under which Mosaic will acquire rights to Oncotelic’s clinical-stage necroptosis cancer therapies. Oncotelic’s necroptosis therapeutics work by disrupting tumor blood flow resulting in immunogenic tumor cell death through “death re